Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

CLARUS THERAPEUTICS INC (CRXT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07
   S-1/AS-1/AS-1/A
Revenues  2.81.81.0
            Revenue growth  50.5%78.7% 
Cost of goods sold  1.51.10.8
Gross profit  1.30.80.3
            Gross margin  46.1%42.0%26.6%
Selling, general and administrative   [+]1.51.10.8
EBIT   [+]-4.2-2.9-1.8
            EBIT margin  -153.9%-158.0%-173.4%
Interest income, net   [+]0.00.00.0
Pre-tax income  -4.2-2.9-1.8
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  0.00.00.0
            Net margin  -0.2%-0.2%-0.2%
   
Basic EPS   [+]($15.13)($10.47)($6.60)
Diluted EPS   [+]($15.13)($10.47)($6.60)
   
Shares outstanding (basic)  0.00.00.0
Shares outstanding (diluted)  0.00.00.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy